Advenchen Laboratories, LLC
Registry sponsor category
Industry
- Other names
- Advenchen Laboratories, LLC
- Company name
- Advenchen Laboratories, LLC
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Publicly traded (proxy)
- No
- Listing at source
- Listed
Related records
Trials (7)
- A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors.
- A Study of AL8326 in Non-Small Cell Lung Cancer
- Catequentinib in Patients Who Have Completed an Advenchen Study (A Compassionate Use Trial)
- Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors
- Phase 1/2a Evaluation of AL3818 in Subjects With Recurrent or Metastatic Endometrial, Ovarian or Cervical Cancer (AL3818-US-001)
- Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002)
- Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)